NYCBS Welcomes Dr.

Keith Brunckhorst to Its Oncology Team

Port Jefferson Station, NY, October 17, 2019 --(PR.com)-- Keith R. Brunckhorst, MD is a talented
physician who is board-certified in medical oncology and hematology. He is experienced and well versed
in the most cutting-edge cancer technology, with an impeccable work history and education. For Dr.
Brunckhorst, patients come first. He pledges to treat each patient with the utmost care and compassion.
He will be practicing at 112 East 83rd Street, New York.

nycancer.com/blog/2019/10/16/nycbs-welcomes-dr-keith-brunckhorst-its-oncology-t/

Dr. Brunckhorst earned his medical degree from New York Medical College, where he received the
Mosby Scholarship Award for his scholastic effort. Dr. Brunckhorst then completed his internship and
residency in Internal Medicine at Stamford Hospital. He also completed his fellowships in hematology
and oncology at Lenox Hill Hospital.

For more than 30 years, Dr. Brunckhorst has been employed at Lenox Hill Hospital, most recently
serving in the esteemed position as Associate Chief and Associate Program Director of Oncology.

In addition, Dr. Brunckhorst has served as an investigator for multiple research projects and also worked
on two publications. He was appointed as a clinical instructor of medicine at Cornell Medical School.

To make an appointment with Dr. Brunckhorst, please call 212-583-2858. For more information, please
visit www.NYcancer.com.

About NYCBS

New York Cancer & Blood Specialists is committed to our patients. We are dedicated to providing each
patient with a unique path to treatment and unmatched support. We strive to make quality,
community-based cancer care available in each and every New York community.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
New York Cancer & Blood Specialists
Jeremy Mutschler, Senior Director of Marketing
631-574-8360
Contact via Email

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/797221

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use